LunaPBC operates LunaDNA, a health-data platform that unites people, communities, and researchers and enables longitudinal discovery. The platform collects a wide range of data including health records, lived experience, disease history, and genomics, with participation from more than 180 countries and communities. LunaDNA provides tools for participant engagement through to data analysis and is built to comply with HIPAA, GDPR, and CCPA using a common data model. The technology transforms traditional patient-disconnected databases into a privacy-protected, longitudinal discovery environment for academia, industry, and community leaders. LunaPBC plans to scale its platform and services by expanding software engineering and marketing teams, increasing community onboarding-to-discovery velocity, augmenting analysis and discovery tools, and enhancing user experience to encourage sharing of more health data and outcomes. The company was founded in 2017 and is headquartered in San Diego, California; its recent financing will support the stated scaling initiatives. LunaPBC operates LunaDNA, a community-owned genomic and health data platform that allows individuals to share DNA files and health information for medical research and receive shares in the company. The platform accepts uploads from vendors such as 23andMe, AncestryDNA, MyHeritage and FamilyTree DNA and uses LunaDNA-generated health surveys; it plans to expand acceptance to whole genome and exome files, RNA, microbiome data, EHRs, and fitness and smart device data. LunaPBC rewards members for sharing data and offers utility to pharmaceutical, insurance, and healthcare IT companies seeking insights to improve therapies and patient outcomes. The company holds a precedent-setting December 2018 SEC qualification recognizing genomic and health data as currency to acquire company shares, enabling members to share in value created by platform research. Leadership is led by CEO and co-founder Bob Kain. The company will use the new funding to accelerate research partnerships, onboard partners such as Genetic Alliance, and expand platform development and marketing teams.

Total raised

$5M

Funding rounds

2

Latest round

Equity

Latest activity

May 2019